Mylan

Biocon and Mylan get USFDA approval to jointly develop biologic product

The proposed biosimilar Pegfilgrastim is one of the six biologic products co-developed by Mylan and Biocon for the global marketplace

India scraps import duties on AIDS drugs to battle shortage in Naco efforts

Government officials have previously said about a lack of participation by local drugmakers in the tenders floated by the Naco to procure drugs.

Biocon to start selling breast cancer drug next month

CANMAb will be available at about 25 percent discount to the current list price of the reference product - Roche's Herceptin - in India, which is already significantly lower than its price in developed markets, it added.<br /><br />

It's a done deal: Mylan gets US nod to buy Strides' unit Agila

The companies will have to divest assets needed to make 11 generic injectable drugs as a condition of approving the deal, the FTC said.<br /><br />

Cabinet clears Mylan's Rs 5,168 cr deal to acquire Agila

Mylan had set the fourth quarter of 2013 as the expected time for the transaction to be completed subject to regulatory approvals.

US drug maker Mylan buys Strides Arcolab unit for $1.6 bn

Generic drugmaker Mylan said it will buy a unit of Strides Arcolab for $1.6 billion to expand its presence in the fast-growing injectable drugs market.